Showing 4,861 - 4,880 results of 11,113 for search 'significantly ((((((we decrease) OR (nn decrease))) OR (mean decrease))) OR (observed decrease))', query time: 0.63s Refine Results
  1. 4861

    Supplementary file 1_Wellness-enhancing effects of the canine growth hormone releasing hormone therapy mediated by plasmid and electroporation in healthy old dogs.docx by Min-Ok Ryu (5072594)

    Published 2025
    “…While mean serum IGF-1 concentrations did not change overall, post-hoc stratification revealed that dogs with low baseline IGF-1 (<90 ng/mL) showed substantial increases, whereas those with high baseline levels tended to decrease. …”
  2. 4862

    Table 6_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  3. 4863

    Image 1_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  4. 4864

    Table 1_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  5. 4865

    Image 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  6. 4866

    Table 7_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  7. 4867

    Table 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  8. 4868

    Table 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  9. 4869

    Table 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  10. 4870

    Image 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  11. 4871

    Image 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  12. 4872

    Table 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  13. 4873

    Table 9_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  14. 4874

    Table 8_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  15. 4875

    Image 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg by Xiyu Song (14914467)

    Published 2025
    “…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
  16. 4876

    Data Sheet 1_Unveiling the effects of land use and intra-seasonal variation on bee and plant diversity and their ecological interactions in vegetation surrounding coffee plantation... by Quebin Bosbely Casiá-Ajché (14234267)

    Published 2024
    “…Additionally, we observed higher visit frequency and richness of bees and plant generality during the second period of the rainy season (July to October), leading to more robust bee–plant interaction networks in the same period. …”
  17. 4877

    Table 1_Association between estimated glucose disposal rate and the risk of atherosclerotic cardiovascular disease: insight from cross-sectional and retrospective cohort studies.do... by Zixuan Wang (35190)

    Published 2025
    “…</p>Results<p>A significant negative linear association between eGDR and ASCVD risk was observed in our study. …”
  18. 4878

    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  19. 4879

    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  20. 4880

    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”